表紙
市場調查報告書

Caspofungin市場(各適應症:念珠菌感染,鵝口瘡,各流通管道:院內藥局,零售藥局,線上藥局):世界產業分析,規模,佔有率,成長,趨勢,預測

Caspofungin Market (Indication - Candidiasis, Thrush; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 839637
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Caspofungin市場(各適應症:念珠菌感染,鵝口瘡,各流通管道:院內藥局,零售藥局,線上藥局):世界產業分析,規模,佔有率,成長,趨勢,預測 Caspofungin Market (Indication - Candidiasis, Thrush; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年04月12日內容資訊: 英文 156 Pages
簡介

本報告提供全球Caspofungin市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 市場概要
  • Caspofungin藥物的簡介
  • 市場規模預測
  • 市場預測
  • 全球性侵入性念珠菌感染的發病率上升

第5章 考察

  • 臨床實驗開發平台分析
  • 全球罹患率與發病率
  • 供應鏈分析
  • 各製造廠商價格分析

第6章 各適應症市場分析

  • 主要調查結果
  • 簡介
  • 市場值佔有率分析
  • 市場分析
    • 念珠菌感染
    • 鵝口瘡
  • 市場魅力度

第7章 各流通管道市場分析與預測

  • 主要調查結果
  • 簡介
  • 市場值佔有率分析
  • 市場分析
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力度

第8章 各地區市場分析與預測

  • 市場值佔有率分析
  • 市場預測
  • 市場規模
  • 市場魅力度

第9章 北美市場

第10章 歐洲市場

第11章 亞太地區市場

第12章 南美市場

第13章 中東·非洲市場

第14章 企業簡介

  • 競爭矩陣
  • 市場佔有率分析
  • 企業簡介
目錄

Caspofungin Market: Overview

This report on the global caspofungin market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a snapshot that provides overall information of various market segments. The research is a combination of primary and secondary researches. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2017 to 2027, considering the macro and micro environmental factors. Growth rate for each segment of the global caspofungin market has been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. The report also provides insights into the key trends of the caspofungin market. The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global caspofungin market.

Market revenue in terms of US$ Mn for the period between 2017 and 2027 along with the compound annual growth rate (CAGR %) from 2019 to 2027 are provided for all the segments, considering 2018 as the base year. The year-on-year growth of the global caspofungin market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding distribution channels of caspofungin, and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Caspofungin Market: Key Segments

Based on indication, the global caspofungin market has been segmented into candidiasis and thrush. In terms of distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Caspofungin Market: Regional Outlook

In terms of region, the global caspofungin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC Countries, South Africa, Israel, and Mexico.

Companies Mentioned in Report

The report also profiles major players in the global caspofungin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Xellia Pharmaceuticals, and Novartis AG.

The global caspofungin market has been segmented as follows:

Global Caspofungin Market, by Indication

  • Candidiasis
  • Thrush

Global Caspofungin Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Caspofungin Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Contents

Section 1 Preface

  • 1.1 Report Scope and Market Segmentation
  • 1.2 Research Highlights

Section 2 Assumptions and Research Methodology

  • 2.1 Assumptions
  • 2.2 Research Methodology

Section 3 Executive Summary

  • 3.1 Global Caspofungin Market Snapshot
  • 3.2 Key Industry Developments

Section 4 Market Overview

  • 4.1 Caspofungin Market Taxonomy
  • 4.2 Caspofungin Drug Introduction
  • 4.3 Global Caspofungin Market Size (US$ Mn) Forecast, 2017-2027
  • 4.4 Global Caspofungin Market: Market Outlook
  • 4.5 Rise in incidence of invasive candidiasis across the globe
    • 4.5.1.Rise in geriatric population
    • 4.5.2.Advantages of echinocandins over other antifungal
    • 4.5.3.Restraints
      • 4.5.3.1 Availability of Generic Drugs
      • 4.5.3.2 Emergence of resistant species
    • 4.5.4 Opportunities
      • 4.5.4.1 Echinocandins, as first line of therapy in candidiasis
      • 4.5.4.2 Expansion of Research and Development in Emerging Markets

Section 5 Key Insights

  • 5.1 Clinical Trial Pipeline Analysis
  • 5.2 Disease Prevalence & Incidence Rate globally with key countries
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis by Manufacturers

Section 6 Global Caspofungin Market Analysis, by Indication

  • 6.1 Key Findings
  • 6.2 Introduction
  • 6.3 Market Value Share Analysis, by Indication
  • 6.4 Market Value Forecast, by Indication, 2017-2027
  • 6.5 Market Analysis, by Indication, 2017-2027
    • 6.5.1 Candidiasis
    • 6.5.2 Thrush
  • 6.6 Market Attractiveness, by Indication

Section 7 Global Caspofungin Market Analysis, by Distribution Channel

  • 7.1 Key Findings
  • 7.2 Introduction
  • 7.3 Market Value Share Analysis, by Distribution Channel
    • 7.5.1. Hospital Pharmacies
    • 7.5.2 Retail Pharmacies
    • 7.5.3 Online Pharmacies
  • 7.6 Market Attractiveness, by Distribution Channel

Section 8 Global Caspofungin Market Analysis, by Region

  • 8.1 Market Value Share Analysis, by Region
  • 8.2 Market Forecast, by Region
  • 8.3 Global Caspofungin Market Attractiveness Analysis, by Region

Section 9 North America Caspofungin Market Analysis

  • 9.1 Market Overview
  • 9.2 Market Value Share Analysis, by Indication
  • 9.3 Caspofungin Market Forecast, by Indication
  • 9.4 Market Value Share Analysis, by Distribution Channel
  • 9.5 Caspofungin Market Forecast, by Distribution Channel
  • 9.6 U.S.
    • 9.6.1 Canada
  • 9.7 Market Attractiveness Analysis
    • 9.7.1 By Country
    • 9.7.2 By Indication
    • 9.7.3 By Distribution Channel

Section 10 Europe Caspofungin Market Analysis

  • 10.1 Market Overview
  • 10.2 Market Value Share Analysis, by Indication
  • 10.3 Caspofungin Market Forecast, by Indication
  • 10.4 Market Value Share Analysis, by Distribution Channel
  • 10.5 Caspofungin Market Forecast, by Distribution Channel
  • 10.6 Market Value Share Analysis, by Country/Sub-region
  • 10.7 Market Forecast, by Country/Sub-region
    • 10.7.1 Germany
    • 10.7.2 U.K.
    • 10.7.3 France
    • 10.7.4 Spain
    • 10.7.5 Italy
    • 10.7.6 Rest of Europe
  • 10.8 Market Attractiveness Analysis
    • 10.8.1 By Country/Sub-region
    • 10.8.2 By Indication
    • 10.8.3 By Distribution Channel

Section 11 Asia Pacific Caspofungin Market Analysis

  • 11.1 Market Overview
  • 11.2 Market Value Share Analysis, by Indication
  • 11.3 Caspofungin Market Forecast, by Indication
  • 11.4 Market Value Share Analysis, by Distribution Channel
  • 11.5 Caspofungin Market Forecast, by Distribution Channel
  • 11.6 Market Value Share Analysis, by Country/Sub-region
  • 11.7 Market Forecast, by Country/Sub-region
    • 11.7.1 China
    • 11.7.2 Japan
    • 11.7.3 India
    • 11.7.4 Australia & New Zealand
    • 11.7.5 Rest of Asia Pacific
  • 11.8 Market Attractiveness Analysis
    • 11.8.1 By Country/Sub-region
    • 11.8.2 By Indication
    • 11.8.3 By Distribution Channel

Section 12 Latin America Caspofungin Market Analysis

  • 12.1 Market Overview
  • 12.2 Market Value Share Analysis, by Indication
  • 12.3 Caspofungin Market Forecast, by Indication
  • 12.4 Market Value Share Analysis, by Distribution Channel
  • 12.5 Caspofungin Market Forecast, by Distribution Channel
  • 12.6 Market Value Share Analysis, by Country/Sub-region
  • 12.7 Market Forecast, by Country/Sub-region
    • 12.7.1 Brazil
    • 12.7.2 Mexico
    • 12.7.3 Rest of Latin America
  • 12.8 Market Attractiveness Analysis
    • 12.8.1 By Country/Sub-region
    • 12.8.2 By Indication
    • 12.8.3 By Distribution Channel

Section 13 Middle East & Africa (MEA) Caspofungin Market Analysis

  • 13.1 Market Overview
  • 13.2 Market Value Share Analysis, by Indication
  • 13.3 Caspofungin Market Forecast, by Indication
  • 13.4 Market Value Share Analysis, by Distribution Channel
  • 13.5 Caspofungin Market Forecast, by Distribution Channel
  • 13.6 Market Value Share Analysis, by Country/Sub-region
  • 13.7 Market Forecast, by Country/Sub-region
    • 13.7.1 GCC Countries
    • 13.7.2 South Africa
    • 13.7.3 Israel
    • 13.7.4 Rest of MEA
  • 13.8 Market Attractiveness Analysis
    • 13.8.1 By Country/Sub-region
    • 13.8.2 By Indication
    • 13.8.3 By Distribution Channel

Section 14 Company Profiles

  • 14.1 Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2 Market Share Analysis, by Company, 2017
  • 14.3 Company Profile
    • 14.3.1 Teva Pharmaceutical Industries Ltd.
      • 14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2 Financial Overview
      • 14.3.1.3 Product Portfolio
      • 14.3.1.4 SWOT Analysis
      • 14.3.1.5 Strategic Overview
    • 14.3.2 Novartis AG
      • 14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2 Financial Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
      • 14.3.2.4 Strategic Overview
    • 14.3.3 Mylan N.V.
      • 14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2 Financial Overview
      • 14.3.3.3 Product Portfolio
      • 14.3.3.4 SWOT Analysis
      • 14.3.3.5 Strategic Overview
    • 14.3.4 Merck & Co., Inc.
      • 14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2 Financial Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
      • 14.3.4.4 Strategic Overview
    • 14.3.5 Fresenius SE & Co. KGaA
      • 14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2 Financial Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
      • 14.3.5.4 Strategic Overview
    • 14.3.6 Gland Pharma Limited (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
      • 14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2 Financial Overview
      • 14.3.6.3 Product Portfolio
      • 14.3.6.4 SWOT Analysis
      • 14.3.6.5 Strategic Overview
    • 14.3.7 Xellia Pharmaceuticals
      • 14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2 Financial Overview
      • 14.3.7.3 Product Portfolio
      • 14.3.7.4 SWOT Analysis
      • 14.3.7.5 Strategic Overview

List of Tables

  • Table 01: Caspofungin Brands in India and their Prices
  • Table 02: Caspofungin Brands in Germany and their Prices
  • Table 03: Pipeline Analysis, by Phase 3 Drugs
  • Table 04: Country Estimated Burden and Prevalence Rate of Candidiasis
  • Table 05: List of Prescription Products
  • Table 06: List of Prescription Products
  • Table 07: List of Generic Prescription Products
  • Table 08: Global Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 09: Global Caspofungin Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 10: Global Caspofungin Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 11: North America Caspofungin Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 12: North America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 13: North America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 14: Europe Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 15: Europe Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 16: Europe Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 17: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 18: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 19: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 20: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 21: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 22: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 23: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 24: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017-2027
  • Table 25: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global Caspofungin Market Snapshot
  • Figure 02: Global Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 03: Market Value Share, by Indication, 2018
  • Figure 04: Market Value Share, by Distribution Channel, 2018
  • Figure 05: Market Value Share, by Region, 2018
  • Figure 06: Global Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 07: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Candidiasis, 2019-2027
  • Figure 08: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Thrush, 2019-2027
  • Figure 09: Global Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 10: Global Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 11: Global Caspofungin Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2027
  • Figure 12: Global Caspofungin Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2027
  • Figure 13: Global Caspofungin Market Revenue (US$ Mn), by Online Pharmacies, 2017-2027
  • Figure 14: Global Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 15: Global Caspofungin Market Value Share, by Region, 2018 and 2027
  • Figure 16: Global Caspofungin Market Attractiveness, by Region, 2019-2027
  • Figure 17: North America Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 18: North America Caspofungin Market Value Share, by Country, 2018 and 2027
  • Figure 19: North America Caspofungin Market Attractiveness, by Country, 2019-2027
  • Figure 20: North America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 21: North America Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 22: North America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 23: North America Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 24: Europe Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 25: Europe Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 26: Europe Caspofungin Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 27: Europe Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 28: Europe Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 29: Europe Caspofungin Market Value Share Analysis, by Distribution Channel
  • Figure 30: Europe Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 31: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 32: Asia Pacific Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 33: Asia Pacific Caspofungin Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 34: Asia Pacific Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 35: Asia Pacific Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 36: Asia Pacific Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 37: Asia Pacific Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 38: Latin America Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 39: Latin America Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 40: Latin America Caspofungin Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 41: Latin America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 42: Latin America Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 43: Latin America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 44: Latin America Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 45: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 46: Middle East & Africa Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 47: Middle East & Africa Caspofungin Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 48: Middle East & Africa Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
  • Figure 49: Middle East & Africa Caspofungin Market Attractiveness, by Indication, 2019-2027
  • Figure 50: Middle East & Africa Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 51: Middle East & Africa Caspofungin Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 52: Teva Pharmaceutical Industries Ltd., Generic Products Revenue (US$ Mn), 2015-2018
  • Figure 53: Teva Pharmaceutical Industries Ltd., Generic Products Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 54 Teva Pharmaceutical Industries Ltd., R&D Expenses (US$ Mn), 2015-2018
  • Figure 55: Teva Pharmaceutical Industries Ltd. Breakdown of Generic Products Net Sales (%), by Region, 2018
  • Figure 56: Sandoz Division Revenue (US$ Mn), 2015-2018
  • Figure 57: Sandoz Division Breakdown of Net Sales (%), by Region, 2018
  • Figure 58: Novartis AG, R&D Expenses (US$ Mn), 2015-2018
  • Figure 59: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 60: Mylan N.V. Revenue (US$ Mn), 2015-2018
  • Figure 61: Mylan N.V., Breakdown of Net Sales (%), by Region, 2018
  • Figure 62: Mylan N.V., R&D Expenses (US$ Mn), 2015-2018
  • Figure 63: Merck & Co., Inc., Revenue (US$ Mn), 2015-2018
  • Figure 64: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
  • Figure 65: Merck & Co., Inc., R&D Expenses (US$ Mn), 2015-2017
  • Figure 66: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 67: Fresenius Kabi AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015-2018
  • Figure 68: Fresenius Kabi AG, Breakdown of Net Sales, by Region, 2018
  • Figure 69: Fresenius Kabi AG, R&D Expenses (US$ Mn), 2015-2018
  • Figure 70: Fresenius Kabi AG, Breakdown of Net Sales, by Product Segment, 2018
  • Figure 71: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Revenue (US$ Mn), 2015-2017
  • Figure 72: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 73: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., R&D Expenses (US$ Mn), 2015-2017
  • Figure 74: Xellia Pharmaceuticals Revenue (US$ Mn), 2015-2018
  • Figure 75: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Region, 2018
  • Figure 76: Xellia Pharmaceuticals, R&D Investment (US$ Mn), 2015-2018
  • Figure 77: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Business Segment, 2018
Back to Top